Biomarker reference
The markers a routine checkup usually skips, and the ones that decide your next thirty years.
Cardiovascular markers describe the risk of arterial disease long before any symptom appears, and the ones that matter most are largely absent from a standard Indian health checkup. A routine lipid panel reports how much cholesterol is being carried; it does not report how many particles are carrying it, which is what determines how much collides with an artery wall. Nor does it capture lipoprotein(a), an inherited risk factor more common in South Asians and invisible on every routine panel. This matters disproportionately in India, where 53.4% of cardiovascular deaths occur before the age of 70 and the share of all deaths that are cardiovascular nearly doubled between 1990 and 2016. Read together, these markers answer a question a cholesterol number alone cannot: how much arterial risk is actually accumulating, and how much of it was inherited rather than acquired.
No marker in this group means much on its own. Heart & long-term risk covers 17 of the measurements in the Peak Brain panel, and a physician reads them as a pattern — one value at the edge of a reference range means something quite different depending on what the others are doing.
These markers are included in the panel and read alongside the ones above. They have no standalone reference page, because outside the context of a full panel there is little useful to say about them individually — and a page that exists only to fill a URL is worse than no page.
Reviewer assignment follows speciality. Pages in this group are assigned to Dr. Nitesh Arora (MD, DM), and each page carries a byline naming its reviewer and the date of review.
ApoB, for most people. It counts the particles capable of lodging in an artery wall rather than weighing the cholesterol inside them, and it predicts events more reliably than LDL cholesterol where the two disagree. Lp(a) is the one to measure once, because it is inherited, more common in South Asians, and never appears on a routine panel.
Frequently, yes. Normal LDL cholesterol with a high ApoB is a common and clinically meaningful pattern, particularly alongside insulin resistance. And Lp(a) is entirely independent of the standard panel — a person can carry substantially elevated lifetime risk with a spotless cholesterol report.
ApoB and hs-CRP respond to intervention and are worth repeating after a meaningful change in diet, weight or medication — ninety days is a reasonable interval. Lp(a) is genetically determined and does not drift, so once in adult life is enough.
The programme
Peak Brain draws a full blood and urine panel at your home, has a licensed physician read every marker together rather than one at a time, and turns what they find into a ranked 90-day protocol with a retest at the end.